找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Neurophysiologic Biomarkers in Neuropsychiatric Disorders; Etiologic and Treatm Daniel C. Javitt,James C. McPartland Book 2024 The Editor(s

[复制链接]
查看: 36021|回复: 54
发表于 2025-3-21 16:36:49 | 显示全部楼层 |阅读模式
书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders
副标题Etiologic and Treatm
编辑Daniel C. Javitt,James C. McPartland
视频video
概述Offers a comparative review of biomarkers across major mental health disorders.Discusses applications to drug development via the 21st Century Cares Act.Presents a translational approach to appeal to
丛书名称Advances in Neurobiology
图书封面Titlebook: Neurophysiologic Biomarkers in Neuropsychiatric Disorders; Etiologic and Treatm Daniel C. Javitt,James C. McPartland Book 2024 The Editor(s
描述.This book reviews neurophysiological biomarkers in neuropsychiatric disorders from the viewpoint of the 21st Century Cures Act, which encourages the use of biomarkers for a variety of purposes during drug development. It covers both traditional etiologic uses of biomarkers and the more recent Biomarkers, EndpointS, and other Tools (BEST) classification scheme used by the FDA, which permits biomarkers for purposes of susceptibility, diagnosis, monitoring, prognosis, pharmacodynamics/response, and safety. The first section of the book describes potential uses of neurophysiologic biomarkers. Subsequent sections focus on a wide range of conditions, including schizophrenia, autism spectrum disorder, Parkinson’s disease, and depression, as well as cross-diagnostic and translational uses, including monkey and rodent analogs. The purpose of the book is to help clinicians understand how neurophysiological biomarkers may be used to understand and manage clinical conditions; to help researchers to understand how biomarkers may be used translationally to test specific theories; and to help pharma investigators to understand how biomarkers can be used to accelerate treatment development..
出版日期Book 2024
关键词schizophrenia; psychiatry; autism; cognition; fMRI; event-related potentials; cerebral blood volume; dement
版次1
doihttps://doi.org/10.1007/978-3-031-69491-2
isbn_softcover978-3-031-69493-6
isbn_ebook978-3-031-69491-2Series ISSN 2190-5215 Series E-ISSN 2190-5223
issn_series 2190-5215
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders影响因子(影响力)




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders影响因子(影响力)学科排名




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders网络公开度




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders网络公开度学科排名




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders被引频次




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders被引频次学科排名




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders年度引用




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders年度引用学科排名




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders读者反馈




书目名称Neurophysiologic Biomarkers in Neuropsychiatric Disorders读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:03:46 | 显示全部楼层
发表于 2025-3-22 02:35:13 | 显示全部楼层
Book 2024use of biomarkers for a variety of purposes during drug development. It covers both traditional etiologic uses of biomarkers and the more recent Biomarkers, EndpointS, and other Tools (BEST) classification scheme used by the FDA, which permits biomarkers for purposes of susceptibility, diagnosis, mo
发表于 2025-3-22 07:06:54 | 显示全部楼层
发表于 2025-3-22 10:16:12 | 显示全部楼层
Biomarker Methodologies: A NIMH Perspectiveel interventions. This chapter highlights examples of biomarker technologies that have been utilized to advance understanding of the pathophysiology of psychiatric disorders and the development of novel therapeutics.
发表于 2025-3-22 16:45:36 | 显示全部楼层
发表于 2025-3-22 18:10:45 | 显示全部楼层
Rodent Models for ASD Biomarker Developmented by current knowledge of genetics, molecular biology, and bioinformatics. These ASD-associated rodent models enable quantifiable biomarker development. Finally, we discuss the prospects of ASD biomarker development.
发表于 2025-3-23 00:57:45 | 显示全部楼层
The Use of Event-Related Potentials in the Study of Schizophrenia: An Overview leading hypotheses about the pathophysiology of schizophrenia. We conclude with an evaluation of both the utility and limitations of ERPs in schizophrenia research and offer recommendations of future directions that may be beneficial to the field.
发表于 2025-3-23 03:58:36 | 显示全部楼层
Gamma Oscillations as a Biomarker of Neural Circuit Function in Psychosis: Where Are We, and Where Devidence for this hypothesis is critically reviewed, focusing on studies in the areas of visual feature binding, auditory steady-state response, and spontaneous gamma activity. The current state of the field is discussed, and recommendations for future directions are presented.
发表于 2025-3-23 09:13:54 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 22:22
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表